A liposomal MRI contrast agent: Phosphatid ylethanolamine-DTPA
✍ Scribed by Chris W. M. Grant; Stephen Karlik; Eugene Florio
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 589 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract **__Objective:__** To prepare the Gd‐DTPA‐loaded poly (lactic‐__co__‐glycolic acid) (PLGA) microbubbles for both ultrasound imaging and MRI imaging. **__Methods:__** Biodegradable high‐molecular‐weight poly (lactic‐__co__‐glycolic acid) (PLGA) was used as an encapsulating vehicle to fab
Unique paramagnetic liposomal contrast agents were synthesized and utilized for selective augmentation of T1 MR imaging of the livers of normal Balb/c mice. A series of amphipathic gadolinium complexes, which mimic phospholipids, was incorporated into the lamella of small unilamellar liposomes such
Given current clinical use of phospholipid hilayer structures (liposomes/vesicles) as nontoxic drug delivery vehicles, we have addressed the possibility of employing the phospholipids themselves as MRI contrast agents. To this end we have synthesized phosphatidylcholine with a nitroxide spin label r
## Abstract A novel, radical responsive MRI contrast agent based on a gadolinium chelate conjugated to a liposome through a disulfide linker was synthesized, with the aim of pursuing the __in vivo__ mapping of radicals. The liposome was prepared by incorporating a thiol‐activated phospholipid, whic
## Abstract Two phospholipids—one bearing a nitroxide free radical covalently attached to its polar headgroup, and the other bearing a similarly attached chelating agent with bound gadolinium—were compared __in vivo__ as liposomal contrast agents for MR imaging. In each case the phospholipid contra